Furthermore, future studies on blocking the lymphocyte inflammation or IL-18/IFN-γ signaling to ameliorate the emphysema phenotype in Hhip+/– murine models and examination of expression of IL-18 in human lung tissue are also warranted to pinpoint the therapeutic applications. This evidence concerns the gene IL18 and pulmonary emphysema.